ODDB.org: Open Drug Database

Rizatrip-Mepha oro 5 mg, Schmelztabletten - 6 Tablette(n)

Swissmedic Key	65035005	Registration Holder	Mepha Pharma AG
Name	Rizatrip-Mepha oro 5 mg, Schmelztabletten	Date of registration	29.09.2014
		Introduction of Sequence	29.09.2014
ATC-Classification	Rizatriptan (N02CC04)	Revision date
WHO	WHO-DDD	Valid until	28.09.2019
Index Therapeuticus (BSV)		Show package size	6 Tablette(n)
Index Therapeuticus (Swissmedic)	02.05.10.	Description
Swissmedic categorie.	B
SL Eintrag	No	Indication
Information for professionals		Consumer information
Ex-factory-Price	PR
Deductible	k.A.	Consumer price	PR
Feedback	FB
GTIN	7680650350057	Medication Code	Synthetika human
Pharmacode		Disponibility

Composition

rizatriptanum 5 mg ut rizatriptani benzoas, aspartamum, aromatica, excipiens pro compresso.

Packungsbestandteile

Galenic Form

Melting tablets

Excipiens

Active Agent	Dose
Rizatriptan	5 mg correspond Rizatriptan Benzoate

Inactive agents
Aromatica
Aspartame

Source

Data was imported : 07.07.2015 Swissmedic Registration : 65035 Sequence : 01 Product name : Rizatrip-Mepha oro 5 mg, Schmelztabletten Registration owner: : Mepha Pharma AG Product group : Index Therapeuticus (BSV) : 02.05.1. Medication Code : Synthetika human Date of registration : 29.09.2014 Valid until : 28.09.2019 Package number : 005 Show package size : 6 Commercial Form/Unit : Tablette(n) Swissmedic categorie. : B Active Agents : rizatriptanum Composition : rizatriptanum 5 mg ut rizatriptani benzoas, aspartamum, aromatica, excipiens pro compresso.

2024	©ywesee GmbH